Intermittent PARP inhibitor regimen in ovarian cancer (IPIROC): A proof-of-concept exploratory pragmatic study (IPIROC#02) using generic rucaparib with pharmacodynamic assessment.
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Authors: Asima Mukhopadhyay, Tanushri Ghosh, Daity Bhattacharjee, Dona Chakraborty, Sib Sankar Roy, Atanu Bhattacharjee, Roma Gupta, Papiya Mukherjee, Somoshree Sengupta, Sharmistha Das, Ranajit Mandal, Puja Chatterjee, Manisha Vernekar, Rahul Roy Chowdhury, Amlan Kanti Sarkar, IPIROC Study Group
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G2653062425
OpenAlex ID: W4410813362